Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neo-Probe sets up Israeli company

This article was originally published in Clinica

Executive Summary

Neo-Probe (US) has invested $3.2 million in a company in Israel to develop its radio-immunoguided (RIGS) technology. In the first stage of the project the company will manufacture the intraoperative cancer detection system, which uses monoclonal antibodies from Dow Chemical, to identify colon cancer. The system will then be adapted for lung and breast cancer detection.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093099

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel